在本研究中,作者采用了具有不同遺傳背景(C57/DBA, C57/129)的小鼠體細胞核移植胚胎干細胞和正常來源的胚胎干細胞作為研究對象,首先用四倍體囊胚重建的方法鑒定了六株胚胎干細胞的全能性。然后利用Bisulfite Genomic Sequencing并結合COBRA方法,對于六株干細胞系的三個印跡基因(H19, Peg1, Peg3)進行分析。研究發(fā)現(xiàn)在長時間體外培養(yǎng)(p20)的四株核移植胚胎干細胞中均存在著不同程度的甲基化異,F(xiàn)象。其中H19表現(xiàn)出了高度動態(tài)的甲基化模式,而Peg3則具有相對穩(wěn)定的甲基化模式。雖然核移植來源的胚胎干細胞具有很好的全能性,但是潛在的印跡異常將成為其在細胞治療中的潛在危險,篩選具有正常表觀遺傳修飾的核移植胚胎干細胞系對于干細胞的臨床應用將是不可或缺得。
常港(中科院動物研究所聯(lián)合培養(yǎng)博士生)為本文的第一作者;參與此項工作的還有,劉勝(技術員),王鳳超博士,張郁(技術員),寇朝輝(技術員);北京生命科學研究所的高紹榮博士和中科院動物研究所的陳大元研究員是本文的共同通訊作者。
此項研究為科技部863和北京市科委資助課題,在北京生命科學研究所高紹榮實驗室完成。
原始出處:
Genomics, In Press, Corrected Proof, Available online 13 November 2008
Differential methylation status of imprinted genes in nuclear transfer derived ES (NT-ES) cells
Gang Chang, Sheng Liu, Fengchao Wang, Yu Zhang, Zhaohui Kou, Dayuan Chen, Shaorong Gao
Compared with fertilized embryo derived ES (F-ES) cells, somatic cell nuclear transfer (SCNT) produced ES (NT-ES) cells were proposed appropriate for cell transplantation based therapies. Although previous studies indicated that NT-ES cells and F-ES cells were transcriptionally and functionally indistinguishable, characterization of DNA methylation patterns of imprinted genes in NT-ES cells is lacking. Here, we show that DNA methylation patterns in the differentially methylated region (DMR) of paternally imprinted gene, H19, displayed distinct abnormalities in certain NT-ES and F-ES cell lines after long-term culture in vitro. DNA methylation profiles of H19 appeared very dynamic in most ES cell lines examined, either hypermethylation or hypomethylation could be observed in specific ES cell lines. In contrast to H19, maternally imprinted genes, Mest and Peg3, showed relatively stable methylation patterns in ES cells, especially Peg3, which displayed better capability in enduring long-term culture in vitro. Our results indicate that abnormal methylation profiles of certain imprinted genes could be observed in both NT-ES and F-ES cell lines after long-term culture in vitro although these cell lines were proved to be pluripotent with germline transmission competent. Stringent screening of epigenetically normal NT-ES cells might be potentially necessary for further therapeutic application of these cells.